Hillhouse

Portfolio Companies 2026 for Hillhouse: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Hillhouse accounts for 15 tracked companies with verified cap-table data, 15 of which disclose round sizes totalling $5.7B. The median disclosed raise is $200M, and the largest is GDS International at $1.6B, ahead of Clover Biopharmaceuticals ($1B) and Xiaohongshu ($900M).

The names that recur most often on these portfolio cap tables are Hillhouse (15 companies), Temasek (2 companies), DST Global (2 companies), Tencent (2 companies), Zhen Fund (2 companies), Rava Partners (1 company). By latest disclosed round, the market skews Series B (6), IPO (2), Series C (2), Series D (2).

Best funded Hillhouse companies

  1. GDS International — $1.6B (latest: Series B)
  2. Clover Biopharmaceuticals — $1B (latest: IPO)
  3. Xiaohongshu — $900M (latest: Series F)
  4. Garena — $722M (latest: Series E)
  5. Fenbeitong — $300M (latest: Series C)
  6. DEEPEXI — $256M (latest: Series B)
  7. Shijiazhuang Junlebao Dairy — $214M (latest: IPO)
  8. Jacobio Pharmaceuticals — $200M (latest: Series C)
  9. Kaikeba.com — $189M (latest: Series B)
  10. Enfusion — $156M (latest: Series D)
  11. Paraview Software — $53M (latest: Series D)
  12. X-EPIC — $46M (latest: Series A)
  13. Tenways — $45M (latest: Series B)
  14. Jinke — $30M (latest: Series B)
  15. Nanovision Technology — $23M (latest: Series B)

Hillhouse Capital Group — related firms and companies (56)

Hillhouse Capital Group profile · All research reports